Cantor Fitzgerald, L. P. »

Trevi Therapeutics shares owned by Cantor Fitzgerald, L. P.

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by Cantor Fitzgerald, L. P. from 13F filings

Historical chart of Cantor Fitzgerald, L. P. investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by Cantor Fitzgerald, L. P. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by Cantor Fitzgerald, L. P.

Quarter filed Position value Share count Share price at filing
2025-09-30 $465k 51k 9.15
2025-06-30 $547k 100k 5.47
2024-12-31 $82k 20k 4.10

More positions owned by Cantor Fitzgerald, L. P.

Strategy Cl A (MSTR)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Advanced Micro Devices (AMD)
Tesla Motors (TSLA)
Robinhood Mkts Com Cl A (HOOD)
Super Micro Computer Inc Com Usd0.001 (SMCI)
UnitedHealth (UNH)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Rocket Lab Corp (RKLB)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Oracle Corporation (ORCL)
Oklo Com Cl A (OKLO)
Broadcom (AVGO)
Rigetti Computing Common Stock (RGTI)

View all positions for Cantor Fitzgerald, L. P.

Top funds holding Trevi Therapeutics

NEA Management Company
Frazier Life Sciences Management
BlackRock
Rubric Capital Management
Vanguard Group
Viking Global Investors
Vivo Capital
Marshall Wace
Alliancebernstein
MPM Oncology Impact Management
OrbiMed Advisors
FMR
Wellington Management Company
Octagon Capital Advisors
Affinity Asset Advisors

View all funds holding Trevi Therapeutics